Huaren Pharmaceutical Co.Ltd(300110) independent director
Independent opinions on the by election of independent directors of the seventh board of directors
As an independent director of the company, we are in accordance with the company law, the securities law, the guiding opinions on the establishment of independent director system in listed companies, the guidelines for the governance of listed companies, the Listing Rules of GEM stocks of Shenzhen Stock Exchange, the guidelines for the standardized operation of GEM listed companies of Shenzhen Stock Exchange and other relevant laws In accordance with the relevant provisions of laws and regulations, normative documents and the articles of association, and in a serious and responsible attitude, the following independent opinions are expressed on the by election of independent directors of the seventh board of directors of the company:
After reviewing the personal resume and other relevant materials of Mr. Liu Yong, the candidate for independent director of the company, we agree that Mr. Liu Yong’s qualification meets the provisions of relevant laws, regulations and the articles of association, his educational background, employment experience and professional ability meet the job requirements of the proposed position, and there is no company law The guidelines for the standardized operation of companies listed on the growth enterprise market of Shenzhen Stock Exchange and the articles of association stipulate that they are not allowed to serve as directors. There is no case that they are determined by the CSRC to be prohibited from entering the market and the prohibition has not been lifted, nor have they been subject to any punishment and punishment by the CSRC and Shenzhen Stock Exchange. The nomination of independent director candidates and the voting procedures of the board of directors comply with relevant laws, regulations and the articles of association. We unanimously agree that Mr. Liu Yong is the candidate for independent director of the seventh board of directors of the company and will be submitted to the first extraordinary general meeting of shareholders of the company in 2022 for deliberation.
(no text on this page)
(there is no text on this page, which is the signature page of Huaren Pharmaceutical Co.Ltd(300110) independent directors’ independent opinions on the by election of independent directors of the seventh board of directors)
Signature of independent director:
(Feng Genfu) (Zhang Tianxi) (he Dalin) Huaren Pharmaceutical Co.Ltd(300110) board of directors December 24, 2001
